Related Experiment Video

Updated: Apr 2, 2026

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

114.4K

Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling

Wei Zhang1, Liraz Levi1, Pallab Banerjee2

  • 1Department of Cellular & Molecular Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Oncotarget
|September 30, 2015
PubMed

Insights

Kruppel-like factor 2 (KLF2) suppresses breast cancer by regulating retinoic acid (RA) signaling. KLF2 promotes tumor-suppressing pathways while inhibiting cancer-promoting ones, improving patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Kruppel-like factor 2 (KLF2) exhibits anticarcinogenic properties, but its precise mechanism in cancer remains unclear.
  • KLF2 is frequently downregulated in human breast cancers, with lower expression correlating with reduced patient survival.

Purpose of the Study:

  • To elucidate the mechanism by which KLF2 exerts its anticarcinogenic effects in breast cancer.
  • To investigate the role of KLF2 in regulating retinoic acid (RA) signaling pathways involved in tumorigenesis.

Main Methods:

  • Analysis of KLF2 expression in human breast cancer tissues and correlation with patient survival.
  • Investigating the impact of KLF2 on the expression of key proteins involved in RA signaling, including CRABP2, FABP5, RARs, and PPARβ/δ.
  • Assessing the functional consequences of KLF2-mediated alterations in RA signaling on tumor development.

Main Results:

  • KLF2 expression is significantly downregulated in breast cancers and inversely correlates with patient survival.
  • KLF2 modulates RA signaling by upregulating CRABP2 and RARγ, while downregulating FABP5 and PPARβ/δ.
  • This shift in RA signaling favors the tumor-suppressive CRABP2/RAR pathway over the pro-carcinogenic FABP5/PPARβ/δ pathway, thereby inhibiting tumor growth.

Conclusions:

  • KLF2 acts as a tumor suppressor in breast cancer by reprogramming RA signaling.
  • KLF2's ability to redirect RA from pro-tumorigenic to anti-tumorigenic pathways highlights its therapeutic potential.
Keywords:
Kruppel-like factorbreast cancernuclear receptorsretinoic acidvitamin A

More Related Videos

Indirect Immunofluorescence on Frozen Sections of Mouse Mammary Gland11:13

Indirect Immunofluorescence on Frozen Sections of Mouse Mammary Gland

Published on: December 1, 2015

39.2K
An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.7K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K